Copyright held by the owner/author(s).
1Department of Communication, University of Utah, Salt Lake City, Utah. 2Huntsman Cancer Institute, Salt Lake City, Utah. *Corresponding Author: Yi Liao, Department of Communication, University of ...
Copyright held by the owner/author(s).
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
1Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York. 2Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, ...
Waltham, MA–based biotech Mural Oncology announced that it will end its phase III trial of nemvaleukin alfa, an engineered fusion protein that selectively binds to the intermediate-affinity IL2 ...
The acting director of the Centers for Disease Control and Prevention (CDC), Susan Monarez, PhD, has been nominated to lead the agency. Prior to moving to the CDC in January, Monarez, who’s held ...
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
Search for other works by this author on: ...
Main Finding: Tumor cells secrete an aminopeptidase that frees amino acids for uptake by neighboring cells, enhancing overall tumor fitness. Concept: Nutrient scavenging, driven by secreted CNDP2, is ...
Menlo Park, CA–based Orca Bio announced that its allogeneic T-cell immunotherapy Orca-T led to a significant improvement in survival without chronic graft-versus-host disease (cGvHD) compared with a ...
Boston, MA–based Dana-Farber Cancer Institute (DFCI) secured approval from the state to build a 300-bed hospital at the current site of the Joslin Diabetes Center in the city’s Longwood Medical Area.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results